Hims & Hers faces key FDA decisions on compounded GLP-1/semaglutide peptides—upside if permitted, downside if restricted.
Hims is a telehealth company offering discreet virtual consultations and prescription delivery for men's health concerns. Hims' hair loss program uses FDA-approved treatments like finasteride and ...
Downgrading Hims & Hers Health, Inc. to Hold as the GLP-1 downside catalysts feel very real now. The FDA signaled new limits on non-approved compounded GLP-1 APIs being mass-marketed, and it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results